Fig. 4: Clinical trials of Treg cell therapy.
From: Harnessing the biology of regulatory T cells to treat disease
Time course of the number of clinical trials investigating regulatory T (Treg) cell therapy, based on data available from ClinicalTrials.gov and EudraCT. Ongoing (striped bars) refers to the number of clinical trials that were registered as recruiting in each given year. Complete (solid bars) refers to the number of clinical trials that were recorded as complete or terminated in each given year. Trials are separated into disease areas. GVHD, graft-versus-host disease.
